CN102872402A - Medicine for treating early threatened abortion - Google Patents

Medicine for treating early threatened abortion Download PDF

Info

Publication number
CN102872402A
CN102872402A CN2012103946849A CN201210394684A CN102872402A CN 102872402 A CN102872402 A CN 102872402A CN 2012103946849 A CN2012103946849 A CN 2012103946849A CN 201210394684 A CN201210394684 A CN 201210394684A CN 102872402 A CN102872402 A CN 102872402A
Authority
CN
China
Prior art keywords
parts
medicine
rhizoma
threatened abortion
early
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2012103946849A
Other languages
Chinese (zh)
Other versions
CN102872402B (en
Inventor
薛洪喜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zibo Blue Ribbon Health Management Co ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201210394684.9A priority Critical patent/CN102872402B/en
Publication of CN102872402A publication Critical patent/CN102872402A/en
Application granted granted Critical
Publication of CN102872402B publication Critical patent/CN102872402B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a medicine for treating early threatened abortion. Common symptoms of early threatened abortion include a small amount of vaginal bleeding after menelipsis, no gestational object discharge, slight hypogastralgia or lumbosacral portion swelling pain. If a patient does not pay attention to fetus protection, inevitable abortion possibly happens. Through a long-term study and clinical verifications, an oral traditional Chinese medicine used for treating the early threatened abortion with a better curative effect is found. The dosages of the components of the medicine disclosed by the invention are obtained after many times of testing, and the medicine optimally comprises the following components: 15 parts of dodder, 15 parts of Chinese taxillus herb, 10 parts of Szechuan lovage rhizome, 12 parts of largehead atractylodes rhizome, 30 parts of dangshen, 10 parts of baical skullcap root, 12 parts of dried tangerine peel, 30 parts of Chinese yam, 20 parts of white paeony root, 10 parts of nutgrass galingale rhizome, 10 parts of cherokee rose fruit, 6 parts of fructus amomi and 6 parts of ass donkey-hide glue. The medicine components are combined to enable the effect of each medicine component to generate a synergistic effect, and the medicine has the effects of cooling blood to stop bleeding, tonifying kidney, preventing fetus and the like, so that the early threatened abortion can be effectively treated.

Description

A kind of medicine for the treatment of the First Trimester threatened abortion
Technical field
The present invention relates to a kind of Chinese herbal medicine, especially a kind of Chinese herbal medicine for the treatment of the First Trimester threatened abortion.
Background technology
First Trimester threatened abortion common sympton is to occur a small amount of colporrhagia after menolipsis, is often kermesinus or sanguinous leukorrhea, without pregnant thing, discharges, and slight lower abdominal pain or lumbosacral region distending pain can occur.The cervix uteri mouth is not opened, and uterus conforms to menopause.If do not note, do not prevent miscarriage, sx↑, may develop into inevitable abortion.
Summary of the invention
The inventor is through studying for a long period of time, and, by the checking repeatedly of clinical trial, finally found the extract oral medicine that is used for the treatment of the First Trimester threatened abortion that better curative effect is arranged, and this medicine has the effects such as cooling blood for hemostasis, tonifying kidney for preventing miscarriage.
Technical assignment of the present invention is to provide a kind of Chinese medicine composition of more efficiently treatment First Trimester threatened abortion.Medicament selection Semen Cuscutae of the present invention, Herba Taxilli, Rhizoma Chuanxiong, the Rhizoma Atractylodis Macrocephalae, Radix Codonopsis, Radix Scutellariae, Pericarpium Citri Reticulatae, Rhizoma Dioscoreae, the Radix Paeoniae Alba, Rhizoma Cyperi, Fructus Rosae Laevigatae, Fructus Amomi, Colla Corii Asini are combined, make each efficacy of drugs produce synergism these drug regimens, thereby can effectively treat the First Trimester threatened abortion.Wherein: Semen Cuscutae: be the mature seed of the annual parasitic voluble herb plant Semen Cuscutae of Convolvulaceae.Property is sweet, puckery, temperature.Return the kidney,liver,spleen warp.Kidney-replenishing, the kidney tonifying essence, improving eyesight, controlling nocturnal emission with astringent drugs, reducing urination, leukorrhagia stopping, antidiarrheal, antiabortive.
Herba Taxilli: be the stem and branch with leaf of Loranthaceae undershrub plant Herba Taxilli.The property sweet, hot, bitter, flat.Return liver, kidney channel.Wind-damp dispelling, the meridian dredging, invigorating the liver and kidney, muscle reinforcing and bone strengthening, antiabortive unit.
Rhizoma Chuanxiong: be the rhizome of Umbelliferae herbaceos perennial Rhizoma Chuanxiong.The property suffering, temperature.GUIXIN, Liver Channel.There is blood-activating and qi-promoting, wind-expelling pain-stopping, effect.
Radix Codonopsis: be the root of campanulaceae herbaceos perennial Radix Codonopsis.The property sweet, flat.Return spleen, lung meridian.The spleen reinforcing lung qi, promote the production of body fluid, and enriches blood.
The Rhizoma Atractylodis Macrocephalae: be the rhizome of the Compositae herbaceos perennial Rhizoma Atractylodis Macrocephalae.Property is sweet, bitter, temperature.Return spleen, stomach warp.Enriching spleen-QI, dampness, diuresis, strengthening superficial resistance to stop perspiration, antiabortive.
Radix Scutellariae: be the root of Labiatae herbaceos perennial Radix Scutellariae.The property hardship, cold.Return lung, spleen, stomach, liver, gallbladder, large intestine, urinary bladder channel.Heat clearing and damp drying, pathogenic fire purging, removing toxic substances, cooling blood for hemostasis.
Pericarpium Citri Reticulatae: be the mature fruit of Rutaceae dungarunga Fructus Citri tangerinae and variety thereof.The property hot, bitter, temperature.Return spleen, lung meridian.During circulation of qi promoting is adjusted, drying dampness to eliminate phlegm.
Rhizoma Dioscoreae: the rhizome of the herbaceous plant Rhizoma Dioscoreae that overgrows for Dioscoreaceae is perennial.The property sweet, flat.Return spleen, lung, kidney channel.Spleen reinforcing lung kidney qi, the strengthening spleen and lung kidney yin.
The Radix Paeoniae Alba: be the root of Ranunculaceae herbaceos perennial Radix Paeoniae.Property is sweet, sour, is slightly cold.Return liver, the heart, spleen channel.Enrich blood, suppressing liver-YANG, relieving spasm to stop pain, hidroschesis.
Rhizoma Cyperi: be the rhizome of Cyperaceae herbaceous plant dried tuber.The property hot, micro-hardship, flat.Return liver, spleen channel.There is depressed liver-energy dispersing and QI regulating, the menstruction regulating and pain relieving effect.
Fructus Rosae Laevigatae: be the mature fruit of the evergreen climbing shrub plant of Rosaceae Fructus Rosae Laevigatae.The property puckery, flat.Return kidney, bladder, large intestine channel.Controlling nocturnal emission with astringent drugs, reducing urination, leukorrhagia stopping, antidiarrheal.
Fructus Amomi: be the dry mature fruit of Zingiberaceae herbaceous plant Fructus Amomi or SEMEN AMOMI LONGILIGULA.The property suffering, temperature.Return spleen, stomach warp.Removing dampness, circulation of qi promoting, warming middle-JIAO, preventing or arresting vomiting.
Colla Corii Asini: for the skin of equine species donkey through decocting, the concentrated solid gum of making.The property sweet, flat.Return lung, liver, kidney, heart channel.Enrich blood, hemostasis, grow lung conscience kidney yin.
The consumption of drug component of the present invention also gropes to draw through the inventor in a large number, and each amounts of components is for to have curative effect preferably in the following weight proportioning: Semen Cuscutae 10-15 part, Herba Taxilli 10-15 part, Rhizoma Chuanxiong 3-10 part, Rhizoma Atractylodis Macrocephalae 5-15 part, Radix Codonopsis 10-30 part, Radix Scutellariae 6-15 part, Pericarpium Citri Reticulatae 3-12 part, Rhizoma Dioscoreae 10-30 part, Radix Paeoniae Alba 10-20 part, Rhizoma Cyperi 6-10 part, Fructus Rosae Laevigatae 6-12 part, Fructus Amomi 5-10 part, Colla Corii Asini 5-15 part
Its best proportioning is: 15 parts of Semen Cuscutae, 15 parts of Herba Taxillis, 10 parts of Rhizoma Chuanxiongs, 12 parts of the Rhizoma Atractylodis Macrocephalaes, 30 parts of Radix Codonopsis, 10 parts of Radix Scutellariaes, 12 parts of Pericarpium Citri Reticulataes, 30 parts of Rhizoma Dioscoreaes, 20 parts of the Radix Paeoniae Albas, 10 parts of Rhizoma Cyperis, 10 parts of Fructus Rosae Laevigatae, 6 parts of Fructus Amomis, 6 parts, Colla Corii Asini
Medicine of the present invention can adopt the conventional method of Chinese medicine preparation to be prepared into any conventional oral preparations, as pill, powder, tablet, oral liquid etc.For example these crude drug pulverize mix homogeneously can be made to powder takes after mixing it with water; Can use decocting, obtain after filtration filtrate, make oral liquid; Also can directly take decoction in case of necessity.
Medicine of the present invention has the effects such as cooling blood for hemostasis, tonifying kidney for preventing miscarriage, and short treating period is evident in efficacy, without any side effects, according to clinical 210 routine patients are observed to statistics, take one of the medicine of the present invention obvious effective rate course for the treatment of 75.24%, two the course for the treatment of 84.76%, three of the obvious effective rate obvious effective rate course for the treatment of 92.86%.
The specific embodiment
Take following each medicine:
15 parts of Semen Cuscutae, 15 parts of Herba Taxillis, 10 parts of Rhizoma Chuanxiongs, 12 parts of the Rhizoma Atractylodis Macrocephalaes, 30 parts of Radix Codonopsis, 10 parts of Radix Scutellariaes, 12 parts of Pericarpium Citri Reticulataes, 30 parts of Rhizoma Dioscoreaes, 20 parts of the Radix Paeoniae Albas, 10 parts of Rhizoma Cyperis, 10 parts of Fructus Rosae Laevigatae, 6 parts of Fructus Amomis, 6 parts, Colla Corii Asini
Said medicine is put in mortar and ground well successively, cross 100 mesh sieves, then packing two pouches; While taking one day twice once a bag, ten days is a course for the treatment of.
Below the clinical data that the patient uses medicine of the present invention:
One, physical data
Accept patient's totally 210 examples for medical treatment, all make a definite diagnosis through gynecologial examination, its age 22-39 year, average 33 years old.
Two, diagnostic criteria
1, occurring a small amount of colporrhagia after menolipsis, is often kermesinus or sanguinous leukorrhea, without pregnant thing, discharges, and slight lower abdominal pain or lumbosacral region distending pain can occur.2, gynecologial examination: the cervix uteri mouth is not opened, and uterus conforms to menopause.3, ultrasonic or β-HCG checks confirmation.
Three, Therapeutic Method
The patient takes medicine of the present invention, and one day twice, once a bag.
Four, efficacy assessment standard
Produce effects: after finishing the course for the treatment of, clinical symptoms disappears fully.
Take a turn for the better: symptom is alleviated substantially.
Invalid: remission is not obvious.
Five, therapeutic outcome
Treatment time Produce effects (example) Obvious effective rate % Take a turn for the better (example) Improvement rate % Invalid (example) Inefficiency %
One course for the treatment of 158 75.24 42 20.00 10 4.76
Two courses for the treatment of 178 84.76 24 11.44 8 3.80
Three courses for the treatment of 195 92.86 10 4.76 5 2.38
Model case:
Mrs Xu, 33 years old, the From Shandong Rizhao people, more than menolipsis February, colporrhagia 1 day, amount is few, and color is dark red, slight lower abdominal pain, color ultrasound examination is shown: single tire in utero, hematocele (20*30mm) in uterine cavity, threatened abortion sign.
Take medicine of the present invention after course for the treatment of, patient's colporrhagia stops, and hypogastralgia alleviates, continue to take medicine of the present invention after course for the treatment of, hypogastralgia disappears, Non-vaginal bleeding, the check color ultrasound: the tire of in utero living, hematocele in uterine cavity few (2*5mm), continue to consolidate curative effect a course for the treatment of.
Mrs Wang, 36 years old, Shandong Zibo people, menolipsis more than 50 days, colporrhagia 2 days, amount is few, and color is dark red, the lower abdomen falling pain, color ultrasound examination is shown: uterine pregnancy capsule 36*42mm size have primitive heart tube to beat, but the gestation sac Tension Difference has threatened abortion sign.
Take medicine of the present invention after course for the treatment of, the patient feels symptom obviously to be alleviated, and colporrhagia obviously reduces, and hypogastralgia disappears, and continues to take medicine of the present invention after course for the treatment of, and colporrhagia stops, and continues to consolidate a course for the treatment of curative effect.

Claims (2)

1. a medicine for the treatment of the First Trimester threatened abortion is characterized in that it is made by the crude drug of following weight proportion:
Semen Cuscutae 10-15 part, Herba Taxilli 10-15 part, Rhizoma Chuanxiong 3-10 part, Rhizoma Atractylodis Macrocephalae 5-15 part, Radix Codonopsis 10-30 part, Radix Scutellariae 6-15 part, Pericarpium Citri Reticulatae 3-12 part, Rhizoma Dioscoreae 10-30 part, Radix Paeoniae Alba 10-20 part, Rhizoma Cyperi 6-10 part, Fructus Rosae Laevigatae 6-12 part, Fructus Amomi 5-10 part, Colla Corii Asini 5-15 part.
2. medicine according to claim 1 is characterized in that it is made by the crude drug of following weight proportion:
15 parts of Semen Cuscutae, 15 parts of Herba Taxillis, 10 parts of Rhizoma Chuanxiongs, 12 parts of the Rhizoma Atractylodis Macrocephalaes, 30 parts of Radix Codonopsis, 10 parts of Radix Scutellariaes, 12 parts of Pericarpium Citri Reticulataes, 30 parts of Rhizoma Dioscoreaes, 20 parts of the Radix Paeoniae Albas, 10 parts of Rhizoma Cyperis, 10 parts of Fructus Rosae Laevigatae, 6 parts of Fructus Amomis, 6 parts, Colla Corii Asini.
CN201210394684.9A 2012-10-17 2012-10-17 Medicine for treating early threatened abortion Active CN102872402B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210394684.9A CN102872402B (en) 2012-10-17 2012-10-17 Medicine for treating early threatened abortion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210394684.9A CN102872402B (en) 2012-10-17 2012-10-17 Medicine for treating early threatened abortion

Publications (2)

Publication Number Publication Date
CN102872402A true CN102872402A (en) 2013-01-16
CN102872402B CN102872402B (en) 2014-04-09

Family

ID=47474072

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210394684.9A Active CN102872402B (en) 2012-10-17 2012-10-17 Medicine for treating early threatened abortion

Country Status (1)

Country Link
CN (1) CN102872402B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103316182A (en) * 2013-05-17 2013-09-25 何圣 Traditional Chinese medicine composition for prevention of habitual abortion
CN105106534A (en) * 2015-08-04 2015-12-02 安徽谓博中药股份有限公司 Anti-abortion drink for pregnant women
CN107970410A (en) * 2017-12-27 2018-05-01 广西壮要方医院有限公司 A kind of medicine for preventing and treating threatened abortion

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1651068A (en) * 2004-12-28 2005-08-10 姬长广 Oral liquid for treating habitual abartion and its dispensing method
CN1985976A (en) * 2006-12-20 2007-06-27 北京润德康医药技术有限公司 Abortion preventing Yimu preparation and its new preparing process
CN101279073A (en) * 2008-04-10 2008-10-08 北京中泰天和科技有限公司 Chinese medicinal composition for curing habitual abortion and method of preparing the same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1651068A (en) * 2004-12-28 2005-08-10 姬长广 Oral liquid for treating habitual abartion and its dispensing method
CN1985976A (en) * 2006-12-20 2007-06-27 北京润德康医药技术有限公司 Abortion preventing Yimu preparation and its new preparing process
CN101279073A (en) * 2008-04-10 2008-10-08 北京中泰天和科技有限公司 Chinese medicinal composition for curing habitual abortion and method of preparing the same

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103316182A (en) * 2013-05-17 2013-09-25 何圣 Traditional Chinese medicine composition for prevention of habitual abortion
CN105106534A (en) * 2015-08-04 2015-12-02 安徽谓博中药股份有限公司 Anti-abortion drink for pregnant women
CN107970410A (en) * 2017-12-27 2018-05-01 广西壮要方医院有限公司 A kind of medicine for preventing and treating threatened abortion

Also Published As

Publication number Publication date
CN102872402B (en) 2014-04-09

Similar Documents

Publication Publication Date Title
CN103182015B (en) Medicament for treating threatened abortion
CN102872418B (en) Medicine for treating pelvic inflammation
CN103341064B (en) Chinese medicine composition for treating urine retention
CN103585378A (en) A Chinese medicinal composition for treating female infertility, and its preparation method
CN103316181A (en) Chinese medicine composition for treating infertility
CN102600426B (en) Chinese medicinal preparation for promoting blood circulation to remove blood stasis and preparation method thereof
CN102872402B (en) Medicine for treating early threatened abortion
CN101912551B (en) Miscarriage-prevention Chinese medicinal composition
CN104173565A (en) Traditional Chinese medicine composition for treating irregular menstruation
CN101690787B (en) Traditional Chinese medicine for treating chronic gastritis and gastric ulcer
CN103263601A (en) Chinese herbal preparation for accelerating fracture post-operation healing and preparation method of Chinese herbal preparation
CN103006980B (en) Chinese medicinal composition for treating distention and fullness
CN101810764B (en) Chinese medicament for treating constipation
CN106421053A (en) Traditional Chinese medicine capable of tonifying spleen and warming stomach
CN103169840B (en) Drug for treating cervical spondylosis
CN103156943B (en) Medicament for treating infertility of obstructive uterine tube
CN102188510B (en) Traditional Chinese medicine composition for treating sand-like cholelithiasis
CN104857490A (en) Traditional Chinese medicine preparation for treating adenoidal hypertrophy and preparation method thereof
CN104857217A (en) Traditional Chinese medicine composition for pregnant woman miscarriage prevention
CN102895580B (en) Pulse invigorating and kidney tonifying medicament
CN104306865A (en) Traditional Chinese medicine preparation for treating threatened abortion
CN105125934A (en) Traditional Chinese medicine composition for treating phlegmatic hygrosis and blood stasis type tubal infertility
CN104587256A (en) Traditional Chinese medicine composition for treating prostatitis
CN104173952A (en) Traditional Chinese medicine composition for treating benign ovarian tumor
CN101716265B (en) Traditional Chinese medicine combination for treating lumer disc hyperosteogeny

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: HAIMEN HUANGHAI PIONEER PARK SERVICES CO., LTD.

Free format text: FORMER OWNER: XUE HONGXI

Effective date: 20150414

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 276800 RIZHAO, SHANDONG PROVINCE TO: 226156 NANTONG, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20150414

Address after: 226156 Nantong Binhai New Area, Haimen City, Hong Kong West Road, No. 999, No.

Patentee after: HAIMEN HUANGHAI PIONEER PARK SERVICES Co.,Ltd.

Address before: 276800 No. 35, hope road, Shandong, Rizhao City

Patentee before: Xue Hongxi

TR01 Transfer of patent right

Effective date of registration: 20181123

Address after: 255000 South District, 20 Floor, Block B, Pioneering Torch Plaza, 111 Liuquan Road, Zibo High-tech Zone, Shandong Province

Patentee after: Zibo blue ribbon Health Management Co.,Ltd.

Address before: 226156 999 Harbour Road, Binhai New Area, Haimen, Nantong, Jiangsu

Patentee before: HAIMEN HUANGHAI PIONEER PARK SERVICES Co.,Ltd.

TR01 Transfer of patent right
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: A drug for treating threatened miscarriage in early pregnancy

Effective date of registration: 20230802

Granted publication date: 20140409

Pledgee: China Construction Bank Co.,Ltd. Zibo Zhangdian sub branch

Pledgor: Zibo blue ribbon Health Management Co.,Ltd.

Registration number: Y2023980050676

PE01 Entry into force of the registration of the contract for pledge of patent right